PT804411E - Analogos sinteticos de acidos gordos poli-insaturados - Google Patents

Analogos sinteticos de acidos gordos poli-insaturados

Info

Publication number
PT804411E
PT804411E PT95935757T PT95935757T PT804411E PT 804411 E PT804411 E PT 804411E PT 95935757 T PT95935757 T PT 95935757T PT 95935757 T PT95935757 T PT 95935757T PT 804411 E PT804411 E PT 804411E
Authority
PT
Portugal
Prior art keywords
acid
pct
glycine
fatty acids
aspartic
Prior art date
Application number
PT95935757T
Other languages
English (en)
Inventor
Merilyn Joy Sleigh
Fred Widmer
Alfred Poulos
Deborah Ann Rathjen
Antonio Ferrante
Paul Adam Schober
Original Assignee
Womens & Childrens Hospital
Peptech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital, Peptech Ltd filed Critical Womens & Childrens Hospital
Publication of PT804411E publication Critical patent/PT804411E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Fats And Perfumes (AREA)
PT95935757T 1994-10-26 1995-10-25 Analogos sinteticos de acidos gordos poli-insaturados PT804411E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM9065A AUPM906594A0 (en) 1994-10-26 1994-10-26 Synthetic polyunsaturated fatty acid analogues

Publications (1)

Publication Number Publication Date
PT804411E true PT804411E (pt) 2003-12-31

Family

ID=3783583

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95935757T PT804411E (pt) 1994-10-26 1995-10-25 Analogos sinteticos de acidos gordos poli-insaturados

Country Status (12)

Country Link
US (1) US5998476A (pt)
EP (1) EP0804411B1 (pt)
JP (1) JPH10508011A (pt)
KR (1) KR100382159B1 (pt)
CN (1) CN1109016C (pt)
AT (1) ATE245626T1 (pt)
AU (1) AUPM906594A0 (pt)
DE (1) DE69531359T2 (pt)
DK (1) DK0804411T3 (pt)
ES (1) ES2203646T3 (pt)
PT (1) PT804411E (pt)
WO (1) WO1996013507A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038688A1 (en) * 1996-04-12 1997-10-23 Peptide Technology Pty. Limited Methods of treating immunopathologies using polyunsaturated fattyacids
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
AU784116B2 (en) * 1999-09-17 2006-02-09 Peplin Biolipids Pty Ltd Anti-cancer nitro- and thia-fatty acids
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
US20030022938A1 (en) * 2001-06-25 2003-01-30 Burstein Sumner H. N-fatty acid-amino acid conjugates and therapeutic uses
KR100477681B1 (ko) * 2002-11-20 2005-03-21 삼성전자주식회사 화상형성장치
CA2436650A1 (en) 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
DE10351111A1 (de) * 2003-11-03 2005-06-16 Langlotz, Rainer Arzneimittel und Verfahren zu ihrer Herstellung
WO2005073164A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
US7544714B2 (en) * 2004-07-16 2009-06-09 University Of Massachusetts Lipid-amino acid conjugates and methods of use
AU2008274876A1 (en) * 2007-02-05 2009-01-15 Children, Youth And Women's Health Service Modulators of antigen-dependent T cell proliferation
EP2598128B1 (en) 2010-07-28 2018-03-28 Life Technologies Corporation Anti- viral azide-containing compounds
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
WO2016130417A1 (en) * 2015-02-11 2016-08-18 Omthera Pharmaceuticals Inc Omega-3 fatty acid prodrug compounds and uses thereof
NZ735250A (en) 2015-07-08 2020-08-28 Research & Business Found Sungkyunkwan Univ Pyrrolidine carboxamido derivatives and methods for preparing and using the same
US11690825B2 (en) 2016-03-09 2023-07-04 Board Of Regents, The University Of Texas System 20-HETE receptor (GPR75) antagonists and methods of use
EP3759070A4 (en) 2018-02-28 2021-12-08 Bridge Biotherapeutics, Inc. WATER-SOLUBLE SALT OF LIPIDATED PEPTIDES AND PROCESS FOR THEIR PRODUCTION AND USE
WO2021151201A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939174A (en) * 1988-02-26 1990-07-03 Shashoua Victor E Appetite suppression with dopamine-fatty acid conjugates
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
HU207287B (en) * 1989-01-17 1993-03-29 Biosignal Kutato Fejlesztoe Kf Polyene fatty acid derivatives of tyrozine-quinaze inhibiting activity and pharmaceutical composition containing them as active component
JPH02225411A (ja) * 1989-02-28 1990-09-07 Nippon Oil & Fats Co Ltd 高度不飽和脂肪酸の溶血性低下方法
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬
SG44524A1 (en) * 1991-06-24 1997-12-19 Adelaide Children S Hospital Methods and compositions of treating malaria and other diseases
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
EP0689835A3 (en) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition containing an amino acid mixture and at least one N-3 fatty acid

Also Published As

Publication number Publication date
EP0804411B1 (en) 2003-07-23
US5998476A (en) 1999-12-07
ES2203646T3 (es) 2004-04-16
CN1109016C (zh) 2003-05-21
DK0804411T3 (da) 2003-11-24
JPH10508011A (ja) 1998-08-04
ATE245626T1 (de) 2003-08-15
WO1996013507A1 (en) 1996-05-09
DE69531359T2 (de) 2004-04-22
KR970707074A (ko) 1997-12-01
AUPM906594A0 (en) 1994-11-17
EP0804411A1 (en) 1997-11-05
CN1167481A (zh) 1997-12-10
KR100382159B1 (ko) 2004-11-16
EP0804411A4 (en) 1999-06-16
DE69531359D1 (de) 2003-08-28

Similar Documents

Publication Publication Date Title
PT804411E (pt) Analogos sinteticos de acidos gordos poli-insaturados
DE60212786D1 (de) Verwendung von polyungesättigten Fettsäuren zur primären Vorbeugung von kardiovaskulären Anfällen
ATE239717T1 (de) Ester und amide von nicht-steroidalen entzündungs-hemmenden carbonsäuren die als anti-oxidantien 5- lipoxygenase-hemmer und nicht-steroidale entzündungs-hemmende mittel verwendet werden können
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
ATE218336T1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
DE3364718D1 (en) Arachidonic acid analogues as anti-inflammatory and antiallergic agents
DE69612755D1 (de) Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen
DE69524639D1 (de) Modifizierte mehrfach ungesättigte fettsäuren
YU89891A (sh) SMEŠE TGF-beta
DE69832520D1 (de) Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
SE9601677D0 (sv) New use
DE3767763D1 (de) Eisen enthaltende zusammensetzung und verfahren zur behandlung von krebs.
ATE164518T1 (de) Verwendung von fettsäuren zur behandlung von abnormalen verkalkung des gewebes
ATE261989T1 (de) Dhc-peptid und dieses enthaltendes mittel
DE60329588D1 (de) Verwendung von epa and dha zur sekundären prevention von schlaganfällen